Skip to main content
. 2017 Mar 21;8(23):37525–37537. doi: 10.18632/oncotarget.16401

Figure 5. Plasma concentrations of serodiagnostic markers of tuberculosis patients during anti-TB treatment.

Figure 5

Concentrations of plasma serodiagnostic markers were measured in 21 TB patients at baseline (BSL) and in 19 TB patients who were followed up at end of month 6 anti-TB treatment. Representative plots are shown for diagnostic markers showing significant differences between the two time points and the vertical bars denote 95% confidence intervals. Corrections were applied within analyses of markers using Fischer Least Significant Differences post hoc testing or Games Howell post hoc depending on homogeneity of variance. All the reported significant p-values were adjusted.